Alder Biopharmaceuticals, Inc.
Uniquely identifies, develops, and manufactures novel antibody therapeutics for autoimmune and inflammatory diseases. The company also enables partners through out-licensing of its technologies.
www.alderbio.com

Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA)
Inhaled therapies for acute and intermittent conditions employing a device that rapidly delivers pure drug
www.alexza.com

Ansaris, Inc. (a division of Locus Pharmaceuticals, Inc.)
Computational drug discovery to design small molecule therapeutic compounds for protein targets.
www.ansarisbio.com

KAI Pharmaceuticals, Inc.
Development of selective modulators of protein kinase isozymes, initially to treat ischemic reperfusion injury
www.kaipharma.com

Labcyte Inc.
Instrumentation using focused acoustic energy to accurately dispense very small quantities of high-value fluids for pharmaceutical research
www.labcyte.com

NeurAxon, Inc.
Developing next generation pain therapeutics
www.nrxn.com

OncoMed Pharmaceuticals, Inc.
OncoMed Pharmaceuticals is a clinical-stage company that discovers and develops novel therapeutics targeting cancer stem cells
www.oncomed.com

Phenomix Corporation
Drug discovery and development company with a portfolio of therapeutic programs in metabolic syndrome and immune disease
www.phenomix.com

ProActa, Inc.
Focused on the treatment of tumors by exploiting their abnormally low concentrations of oxygen (hypoxia)
www.proacta.com

PTC Therapeutics, Inc.
Development of orally active small molecules that modulate post-transcriptional processes
www.ptcbio.com

Relypsa, Inc.
Discovery and development of new non-absorbed polymeric drugs for important applications in cardiovascular and renal disease.
www.relypsa.com

Seattle Genetics, Inc. (Nasdaq: SGEN)
Development of monoclonal antibody (mAb)-based therapeutics for cancer and other human diseases
www.seagen.com